News items related to: News
-
#TreatPeopleRight – Highlights from the ITPC Annual Review
Campaign activity contributing to combined savings of US$700 million for health budgets is among ITPC’s 2016 highlights. The mission of...
-
Infographic: How civil society action led to price reductions in Argentina
Civil society action means 27,000 more people could receive HIV treatment for 10 years. The price of 2 key HIV...
-
I-MAK challenges validity of remaining Hepatitis C drug patent
Legal challenge to unblock Hep C Treatment for up to 13 million people. In a move that could strike down...
-
US-Argentina patent agreement presents public health concern
An alarming unbalanced three-year agreement could result in more unmerited patents in Argentina. As a global coalition of treatment activists...
-
Brazilian Activists: Third-party in a legal case, to prevent weakening of patent system
On April 7, the Working Group on Intellectual Property of the Brazilian Network for the Integration of Peoples (GTPI/Rebrip), filed...
-
Infographics: Who’s benefitting from the abuse of Thailand’s patent system – and how
Our partner, the AIDS Access Foundation in Thailand, has produced a series of infographics, highlighting who is filing for patents...
-
Brazil: People waiting for Hep C cure caught between a life-changing decision – and an attempt to block it
Anvisa’s decision would allow the purchase of generics, and increase access to quality Hep C treatment – but a simultaneous...
-
Advocating for an improved patent applications process in Ukraine
The decision to grant or refuse a patent has an impact on the price of essential medicines – and huge...
-
Thai decision to ‘speed up’ drug patents would threaten access to medicines
Global community on access to medicines calls on Thai PM to retain a pro public health stance. The Thai government,...
-
Argentina: GEP filed new opposition to patent request for Hepatitis C drug
A significant step in ensuring access to treatment for the 800,000 people living with hepatitis C in Argentina. Earlier this...
-
All-Ukrainian Network of PLHIV continues to struggle for affordable LPV/r
Network of people living with HIV submits second opposition to patent on essential HIV drug in Ukraine. On 30 January...
-
Brazilian National Institute of Industrial Property Rejects Truvada® Patent Application
On 24 January 2017, Brazil’s National Institute of Industrial Property (INPI) made public a decision to reject the patent application...
